Sanne Ten Hoorn

4PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 05, 2023
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.

David Pesántez, Sanne Ten Hoorn, Isidro Machado

|Mar 17, 2022
Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Ronja S Adam, Dennis Poel, Leandro Ferreira Moreno

|Jul 13, 2021
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.

Sanne Ten Hoorn, Dirkje W Sommeijer, Faye Elliott

|Jun 02, 2021
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Sanne Ten Hoorn, Tim R de Back, Dirkje W Sommeijer

Pageof 1